S. 2641 (119th)Bill Overview

Health Care Freedom and Choice Act

Health|Health
Cosponsors
Support
Republican
Introduced
Aug 1, 2025
Discussions
Bill Text
Current stageCommittee

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Introduced
Committee
Floor
President
Law
Congressional Activities
01 · The brief
Plain-English summaryWhat this bill actually does

The bill, titled the Health Care Freedom and Choice Act, states that the final interagency rule published by the Internal Revenue Service, the Employee Benefits Security Administration, and the Centers for Medicare & Medicaid Services at 89 Fed. Reg. 23338 (April 3, 2024), relating to Short-Term, Limited-Duration Insurance and Independent, Noncoordinated Excepted Benefits Coverage, "shall have no force or effect." In short, the bill would nullify that 2024 federal rule and remove it from being operative federal policy.

Why people may split

Whether nullifying the rule increases consumer choice and lowers short-term costs (conservative view) versus whether it weakens consumer protections and the ACA insurance risk pool (liberal view).

Watch point

Relative to its intended legislative type, this bill narrowly and clearly accomplishes a single substantive change—the nullification of a specified interagency final rule—using a simple statutory declaration without additional procedural or fiscal provisions.

The bill, titled the Health Care Freedom and Choice Act, states that the final interagency rule published by the Internal Revenue Service, the Employee Benefits Security Administration, and the Centers for Medicare & Medicaid Services at 89 Fed.

Reg. 23338 (April 3, 2024), relating to Short-Term, Limited-Duration Insurance and Independent, Noncoordinated Excepted Benefits Coverage, "shall have no force or effect." In short, the bill would nullify that 2024 federal rule and remove it from being operative federal policy.

Passage30/100

On content alone the bill is procedurally simple and narrowly targeted, which can aid passage. However, it addresses a politically charged area of health regulation, contains no built‑in compromise measures, and would require agreement across both chambers and enactment by the Presidency. Those features lower its overall likelihood absent broader legislative dealmaking or clear majority alignment.

CredibilityPartially aligned

Relative to its intended legislative type, this bill narrowly and clearly accomplishes a single substantive change—the nullification of a specified interagency final rule—using a simple statutory declaration without additional procedural or fiscal provisions.

Contention70/100

Whether nullifying the rule increases consumer choice and lowers short-term costs (conservative view) versus whether it weakens consumer protections and the ACA insurance risk pool (liberal view).

02 · What it does

Who stands to gain, and who may push back.

Likely benefits vs burdens50% / 50%
Federal agencies · ConsumersConsumers · Federal agencies

These are examples from the analysis, not a ranked list of the most-affected groups.

Likely helped
  • Federal agenciesReduces a federal regulatory requirement by striking down an interagency rule, which supporters would say lowers compli…
  • ConsumersSupporters may argue it preserves or expands consumer access to short-term and excepted-benefit products that are typic…
  • Potential benefitMay increase market competition among insurers offering non-ACA-compliant short-term or excepted-benefit policies, whic…
Likely burdened
  • ConsumersCritics may say nullifying the rule removes consumer protections or clarifications intended to limit misuse of short-te…
  • Federal agenciesMay destabilize ACA-compliant individual insurance markets if sicker enrollees remain in comprehensive plans while heal…
  • Federal agenciesCould increase uncompensated care or shift costs to Medicaid/state programs and hospitals if greater use of limited-cov…
03 · Why people split

Why the argument around this bill splits.

Whether nullifying the rule increases consumer choice and lowers short-term costs (conservative view) versus whether it weakens consumer protections and the ACA insurance risk pool (liberal view).
Progressive15%

A mainstream progressive reader would likely view the bill as an effort to roll back a federal rule that governs short-term limited-duration insurance and certain excepted benefits.

Because progressives typically prioritize comprehensive coverage, protections for people with preexisting conditions, and minimizing market segmentation that undermines the Affordable Care Act (ACA) risk pool, they would be wary that nullifying a regulation could reduce protections or enable more limited "junk" plans.

They would emphasize potential harms to coverage continuity and to people who rely on comprehensive marketplace protections.

Likely resistant
Centrist50%

A centrist/moderate would see a single-purpose bill nullifying an interagency rule as a substantive but narrowly targeted action.

They would treat the bill as raising tradeoffs between consumer choice and consumer protection, and would look for evidence from the rulemaking record about its actual effects on coverage, premiums, and market stability.

Their reaction would hinge on whether the 2024 rule made meaningful restrictive or permissive changes and on whether nullification creates clearer, simpler policy or more regulatory uncertainty.

Split reaction
Conservative85%

A mainstream conservative would likely welcome nullifying an interagency rule if they view that rule as an example of federal overreach or as limiting consumers’ ability to choose lower-cost, temporary insurance alternatives.

Conservatives who prioritize market flexibility and reduced federal regulation would see this bill as restoring consumer choice and limiting administrative action by agencies.

They would, however, note the need to avoid unintended harms to continuity of coverage and potential legal challenges.

Leans supportive
04 · Can it pass?

The path through Congress.

Introduced

Reached or meaningfully advanced

Committee

Reached or meaningfully advanced

Floor

Still ahead

President

Still ahead

Law

Still ahead

Passage likelihood30/100

On content alone the bill is procedurally simple and narrowly targeted, which can aid passage. However, it addresses a politically charged area of health regulation, contains no built‑in compromise measures, and would require agreement across both chambers and enactment by the Presidency. Those features lower its overall likelihood absent broader legislative dealmaking or clear majority alignment.

Scope and complexity
24%
Scopenarrow
24%
Complexitylow
Why this could stall
  • The bill provides no cost estimate or analysis of downstream fiscal impacts; absent budgetary information, it's unclear how scorekeepers or committees will treat potential indirect fiscal effects.
  • The legislative pathway (committee action, floor scheduling, availability of procedural vehicles) is unknown; procedural strategy could materially affect chances.
05 · Recent votes

Recent votes on the bill.

No vote history yet

The bill has not accumulated any surfaced votes yet.

06 · Go deeper

Go deeper than the headline read.

Included on this page

Whether nullifying the rule increases consumer choice and lowers short-term costs (conservative view) versus whether it weakens consumer pr…

On content alone the bill is procedurally simple and narrowly targeted, which can aid passage. However, it addresses a politically charged…

Unlocked analysis

Relative to its intended legislative type, this bill narrowly and clearly accomplishes a single substantive change—the nullification of a specified interagency final rule—using a simple statutory declaration without add…

Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.

Perspective breakdownsPassage barriersLegislative design reviewStakeholder impact map
Open full analysis